Jefferies initiates MedinCell’s coverage with a “Buy” recommendation
January 4, 2024
January 4, 2024
Half-Year results (April 2023 – September 2023)
December 19, 2023
December 19, 2023
MedinCell applauds Teva and Royalty Pharma collaboration to further accelerate olanzapine LAI program
November 13, 2023
November 13, 2023
MedinCell at the 2023 Jefferies Global Healthcare Conference -London, 14-16 November
November 6, 2023
November 6, 2023
MedinCell and the European Investment Bank (EIB) have replaced a financial covenant of their ongoing loan agreement to better fit with MedinCell business model
